Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data

Figure 1

Study profile of 391 patients who received NAC and subsequently underwent surgery between September, 2009 and December, 2018. Of these, 243 patients met the eligibility criteria and were enrolled in this study. NAC = neoadjuvant chemotherapy.